Table 1 Baseline characteristics of investigated studies
From: Publication of clinical trials on medicinal products: follow-up on trials authorized in Hungary
All trials authorized in 2012 (n=330) | Trials authorized in 2012 and completed for more than one year in 2020 (n=232) | |
|---|---|---|
% | % | |
Number of involved countries (one or more) | ||
- National trial - International trial | 3.03 96.96 | 1.72 98.28 |
Sponsor | ||
- Industry - Non-industry | 96.96 2.72 | 98.7 1.3 |
Funder | ||
- Industry - Non-industry - Not clear | 94.24 1.51 4.24 | 94.83 0.43 4.74 |
Therapeutic area | ||
- Infectious diseases - Cancer - Musculoskeletal disorders - Gastrointestinal diseases - Respiratory tract diseases - Nervous system diseases - Cardiovascular diseases - Nutritional and metabolic diseases - Immune system diseases - Other | 5.45 22.72 10.9 8.48 7.57 8.48 7.87 7.87 8.18 13.28 | 6.47 20.26 11.64 8.62 8.19 7.33 5.60 9.05 8.19 14.66 |
Registration | ||
- Registered in EU-CTR only | 10.30 | 8.19 |
- Registered in both EU-CTR and ClinicalTrials.gov | 89.70 | 91.81 |